ESC & iPSC News Volume 9.13 | Apr 9 2014

    0
    114

    ESC & iPSC News 9.13 April 9, 2014

    ESC & iPSC News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  ESC & iPSC News on Twitter

     
    TOP STORY
    Scientists Smash Barrier to Growing Organs from Stem Cells
    Scientists have overcome one of the greatest challenges in biology and taken a major step toward being able to grow whole organs and tissues from stem cells. By manipulating the appropriate signaling, the researchers have turned embryonic stem cells into a fish embryo, essentially controlling embryonic development. [Press release from the University of Virginia School of Medicine discussing online prepublication in Science]
    Press Release | Abstract
    Webinar: Modeling Human Neurological Disease with iPS Cells

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    Optical Control of Muscle Function by Transplantation of Stem Cell-Derived Motor Neurons in Mice
    Researchers generated murine embryonic stem cell-derived motor neurons that express the light-sensitive ion channel channelrhodopsin-2, which they then engrafted into partially denervated branches of the sciatic nerve of adult mice. These engrafted motor neurons not only reinnervated lower hind-limb muscles but also enabled their function to be restored in a controllable manner using optogenetic stimulation. [Science]
    Abstract | Press Release | Video

    Kinome-Wide Functional Analysis Highlights the Role of Cytoskeletal Remodeling in Somatic Cell Reprogramming
    The authors report a kinome-wide RNAi-based analysis to identify kinases that regulate somatic cell reprogramming to induced pluripotent stem cells (iPSCs). They prepared 3,686 small hairpin RNA lentiviruses targeting 734 kinase genes covering the entire mouse kinome and individually examined their effects on iPSC generation. [Cell Stem Cell] Abstract | Graphical Abstract

    Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons
    Amyotrophic lateral sclerosis (ALS) presents motoneuron (MN)-selective protein inclusions and axonal degeneration but the underlying mechanisms of such are unknown. Using induced pluripotent cells (iPSCs) from patients with mutation in the Cu/Zn superoxide dismutase (SOD1) gene, researchers show that spinal MNs, but rarely non-MNs, exhibited neurofilament aggregation followed by neurite degeneration when glia were not present. [Cell Stem Cell] Abstract | Graphical Abstract | Press Release

    CG Hypomethylation in Lsh-/- Mouse Embryonic Fibroblasts Is Associated with De Novo H3K4me1 Formation and Altered Cellular Plasticity
    Reprogramming of Lsh-/- murine embryonic fibroblasts into induced pluripotent stem (iPS) cells leads to increased neuronal lineage gene expression of premarked genes and enhanced differentiation potential of Lsh-/- iPS cells toward the neuronal lineage pathway compared with WT iPS cells in vitro and in vivo. [Proc Natl Acad Sci USA] Abstract

    Biologically-Active Laminin-111 Fragment that Modulates the Epithelial-to-Mesenchymal Transition in Embryonic Stem Cells
    The authors report a biologically-active laminin-111 fragment generated by matrix metalloproteinase 2 (MMP2) processing, which is highly up-regulated during differentiation. They showed that the β1-chain-derived fragment interacts via α3β1-integrins, thereby triggering the down-regulation of MMP2 in mouse and human embryonic stem cells. [Proc Natl Acad Sci USA] Abstract

    Tbx1 Modulates Endodermal and Mesodermal Differentiation from Mouse Induced Pluripotent Stem Cells
    Researchers generated induced pluripotent stem cells (iPSCs) from T-box transcriptional factor-/- (Tbx1-/-) and Tbx1+/+ fibroblasts and investigated the spontaneous differentiation potential of iPSCs by detailed lineage analysis of the iPSC-derived embryoid bodies. [Stem Cell Dev] Abstract

    Natural Killer Cell Subsets Differentially Reject Embryonic Stem Cells Based on Licensing
    Mouse or human embryonic stem cells (ESCs) were subjected to cytotoxicity assays involving their respective species-matched activated natural killer (NK) cells. Mouse ESCs were then transplanted to allogeneic recipients after depletion of NK cell subsets in the host. ESC engraftment was analyzed by bioluminescent imaging. [Transplantation] Abstract

    Induce Neural Progenitor Cells Faster and More Effectively - Watch New Technical Video

     
    REVIEWS
    iPS Cell Technologies: Significance and Applications to Central Nervous System Regeneration and Disease
    The authors outline the current status of applications of induced pluripotent stem (iPS) technology to cell therapies (particularly for spinal cord injury), as well as neurological disease-specific iPS cell research (particularly for Parkinson’s disease and Alzheimer’s disease). [Mol Brain] Full Article

    Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.

    Attend the 9th Annual World Stem Cells & Regenerative Medicine Congress in London!

     
    INDUSTRY NEWS
    inGenious Targeting Laboratory Launches a New FLP Embryonic Stem Cell Line for Faster Mouse Models Generation
    inGenious Targeting Laboratory announced the availability of a new embryonic stem “ES” cell line. When used in the creation of genetically modified mice, these proprietary ES cells have a significant impact in reducing both the timeline and cost of generating mouse models. [inGenious Targeting Laboratory] Press Release

    UTSA Doctoral Students Launch Mobile Stem Care Company that Helps Animals
    Two University of Texas at San Antonio (UTSA) biomedical engineering doctoral students, Ramon Coronado and Tony Yuan, have launched Mobile Stem Care LLC, a company that will help veterinarians treat their patients with the latest advancements in stem cell therapies. [The University of Texas at San Antonio] Press Release

    New wallchart from our sponsor:
    Mesenchymal Stem Cells (a Nature Reviews Molecular Cell Biology collaboration). Request your free copy.

     
    POLICY NEWS
    NIH Stem-Cell Program Closes
    Stem-cell researchers at the US National Institutes of Health (NIH) have been left frustrated and confused following the demise of the agency’s Center for Regenerative Medicine. The intramural program’s director, stem-cell biologist Mahendra Rao, left the NIH and the center’s website was taken down. [Nature News] Editorial

    European Commission Report Urges Legal Reform to Help Scientists Text-Mine Research Papers
    European copyright law should change to help researchers use computer programs to extract facts and data from published research papers, legal experts have urged in a report for the European Commission. [Nature News] Editorial | Report

    Former U.S. Research Fraud Chief Speaks Out on Resignation, ‘Frustrations’
    David Wright, the director of the federal Office of Research Integrity, which keeps watch on fraud in federally funded biomedical research, quit in frustration after two years. His resignation letter was a scathing critique of what he called the “dysfunctional” bureaucracy at the Office of the Assistant Secretary for Health. [ScienceInsider] Editorial

    European Parliament Approves Bill to Increase Clinical Trial Transparency
    Researchers who do clinical trials in the European Union will have to make the results public under a bill approved by the European Parliament. In a sweeping vote, 594 members of the Parliament voted in favor of the plan, while only 17 voted against and 13 abstained. [ScienceInsider] Editorial

    DARPA Carves Out New Division to Entice Biotech Talent
    The U.S. Department of Defense’s research arm is making a concerted grasp at biotechnology. The Defense Advanced Research Projects Agency (DARPA) announced a new division that will consolidate biology research scattered across its existing six divisions and possibly expand the arsenal of projects. [ScienceInsider] Editorial

     
    EVENTS
    NEW Future Investigators of Regenerative Medicine (FIRM) Symposium 2014
    September 8-11, 2014
    Girona, Spain

    Visit our events page to see a complete list of events in the ESC & iPSC community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Position – Stem Cell Biology (Yale Stem Cell Center)

    Postdoctoral Research Fellow / Research Officer – Stem Cell Research (Bioprocessing Technology Institute)

    Postdoctoral Fellow – Stem Cell Research (Washington University School of Medicine)

    Postdoctoral Position – Embryonic Stem Cells and Chromatin Biology (University of Michigan)

    Postdoctoral Position – TGFβ-Signaling Pathway in Embryonic Stem Cells (Tsinghua University)

    Stem Cell Research Technician (Van Andel Research Institute)

    Postdoctoral Position – Stem Cells and Epigenetics (Mount Sinai School of Medicine)

    Director of GMP/GLP Quality Operations (University of Pennsylvania, Perelman School of Medicine)

    Postdoctoral Position – Human Stem Cell Biology and Hematopoiesis (Johns Hopkins University School of Medicine)

    Postdoctoral Positions – Stem Cells (CREI Stem Cells, SkolTech)

    Research Associate – Cell Separation (STEMCELL Technologies Inc.)

    Research Technologist – Pluripotent Stem Cells (STEMCELL Technologies Inc.)

    Research Technologist – Particle Chemistry (STEMCELL Technologies Inc.)

    Research Technologist – PSC Biology and Bioengineering (STEMCELL Technologies Inc.)


    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

    Comments or suggestions? Submit your feedback here.

    Learn more about ESC & iPSC News: Archives | Events | Contact Us